Institutional investors purchased a net $1.1 million shares of EBS during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 70.03% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PANAGORA ASSET MANAGEMENT, INC. Bought 223.8 Thousand shares of Emergent BioSolutions Inc